[Paraneoplastic lupus anticoagulans syndrome]

Zentralbl Chir. 2005 Aug;130(4):372-4. doi: 10.1055/s-2005-836796.
[Article in German]

Abstract

The antiphospholipid antibody syndrome (Lupus anticoagulans syndrome) is a rare form of coagulopathy due to the presence of autoantibodies against phospholipids or phospholipid-binding protein cofactors that can lead to vascular thrombosis. We report the case of a 57-year-old female patient presenting with decompensated duodenal stenosis due to a pancreatic tumor. Perioperative testing of coagulation markers revealed with 26 % a strongly decreased Quick-Test and with 81.4 s a prolonged partial thromboplastin time that persisted despite intravenous application of 80 mg vitamin K (Konakion) and 10 units of fresh frozen plasma. Subsequent screening for common causes of thrombophilia revealed antiphospholipid antibodies. Consequently, low molecular weight heparin (Dalteparin-Natrium) was administered perioperatively while a gastroenterostomy with entero-enterostomy was performed with uneventful postoperative course. With this presentation and an analysis of the contemporary literature we would like to discuss different aspects of Lupus anticoagulans syndrome.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome* / diagnosis
  • Dalteparin / administration & dosage
  • Dalteparin / therapeutic use
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use
  • Follow-Up Studies
  • Humans
  • Lupus Coagulation Inhibitor*
  • Middle Aged
  • Pancreatic Neoplasms* / surgery
  • Paraneoplastic Syndromes*
  • Postoperative Care
  • Preoperative Care
  • Thrombosis / etiology
  • Thrombosis / prevention & control
  • Time Factors
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Lupus Coagulation Inhibitor
  • Dalteparin